167 related articles for article (PubMed ID: 2567045)
1. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
Langlade-Demoyen P; Hoffenbach A
Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
[No Abstract] [Full Text] [Related]
2. AIDS 1989. Vaccines and immunology: overview.
Laurence J; Schild GC
AIDS; 1989; 3 Suppl 1():S97-100. PubMed ID: 2514762
[No Abstract] [Full Text] [Related]
3. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
Mills KH; Nixon DF; McMichael AJ
AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
[No Abstract] [Full Text] [Related]
4. [Analytic and integrative perspectives for HIV vaccine design].
Yamamoto H
Uirusu; 2013; 63(2):219-32. PubMed ID: 25366056
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
[TBL] [Abstract][Full Text] [Related]
6. A strategy for prophylactic vaccination against HIV.
Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
[No Abstract] [Full Text] [Related]
7. Use of vaccinia virus vectors for development of AIDS vaccines.
Moss B
AIDS; 1988; 2 Suppl 1():S103-5. PubMed ID: 3147660
[No Abstract] [Full Text] [Related]
8. Why can't cytotoxic T cells handle HIV?
Bevan MJ; Braciale TJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5765-7. PubMed ID: 7597026
[No Abstract] [Full Text] [Related]
9. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
Zinkernagel RM; Hengartner H
Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
[TBL] [Abstract][Full Text] [Related]
10. AIDS pathogenesis: a finite immune response to blame?
Miedema F; Klein MR
Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
[No Abstract] [Full Text] [Related]
11. HIV-gag-specific cytotoxic T lymphocytes.
Nixon DF; McMichael AJ
Res Immunol; 1989 Jan; 140(1):107-10; discussion 121. PubMed ID: 2657907
[No Abstract] [Full Text] [Related]
12. The lucky ones. How do some HIV-positive people avoid getting AIDS?
Beardsley T
Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
[No Abstract] [Full Text] [Related]
13. Harming and protecting responses to HIV.
Lanzavecchia A
Res Immunol; 1989 Jan; 140(1):99-103; discussion 123-4. PubMed ID: 2567046
[No Abstract] [Full Text] [Related]
14. Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity.
Ostrowski MA; Yu Q; Yue FY; Liu J; Jones B; Gu XX; Loutfy M; Kovacs CM; Halpenny R
Immunol Res; 2006; 35(1-2):89-102. PubMed ID: 17003512
[TBL] [Abstract][Full Text] [Related]
15. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
Snart RS
AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
[No Abstract] [Full Text] [Related]
16. The challenge of immune control of immunodeficiency virus.
Richman D
J Clin Invest; 1999 Sep; 104(6):677-8. PubMed ID: 10491402
[No Abstract] [Full Text] [Related]
17. Cytotoxic T-cell recognition of HIV proteins and peptides.
Nixon DF; McMichael AJ
AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
[No Abstract] [Full Text] [Related]
18. AIDS--an autoimmune model.
Kennedy JR
Med Hypotheses; 1992 Jan; 37(1):16-9. PubMed ID: 1349151
[TBL] [Abstract][Full Text] [Related]
19. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
20. Use of herpesvirus saimiri-immortalized macaque CD4(+) T cell clones as stimulators and targets for assessment of CTL responses in macaque/AIDS models.
Kumar A; Stipp HL; Sheffer D; Narayan O
J Immunol Methods; 1999 Nov; 230(1-2):47-58. PubMed ID: 10594353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
